+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid udca in chronic active hepatitis results of a controlled trial



Ursodeoxycholic acid udca in chronic active hepatitis results of a controlled trial



Journal of Hepatology 13(Suppl. 2): S104




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 034144947

Download citation: RISBibTeXText

DOI: 10.1016/0168-8278(91)91388-w


Related references

Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study. European Journal of Clinical Pharmacology 40(5): 473-476, 1991

Alpha interferon alpha ifn vs alpha ifn plus ursodeoxycholic acid udca in chronic hepatitis c ch c a controlled randomized trial. Journal of Hepatology 16(Suppl. 1): S48, 1992

Ursodeoxycholic acid udca improves serum albumin levels in chronic active hepatitis. Gastroenterology 98(5 Part 2): A606, 1990

Ursodeoxycholic acid udca in chronic hepatitis a double blind multicenter clinical trial. Gastroenterology 100(5 Part 2): 719, 1991

Effect of ursodeoxycholic acid udca on liver function lf in patients with chronic active hepatitis and cirrhosis. European Journal of Clinical Investigation 20(2 Part 2): A62, 1990

Ursodeoxycholic acid udca improves serum protein level in patients with chronic active hepatitis. Hepatology 12(4 Part 2): 998, 1990

Effect of ursodeoxycholic acid udca on serum enzymes and liver histology in patients with chronic active hepatitis cah. Journal of Hepatology 13(Suppl. 2): S92, 1991

S1881 The Therapeutic Efficacy of Ursodeoxycholic Acid (Udca) in Drug-Induced Liver Injury: Results of a Randomized Controlled Trial. Gastroenterology 138(5): S-809, 2010

Ursodeoxycholic acid improves liver tests in chronic hepatitis: Results of a randomised controlled trial. Clinical Drug Investigation 17(6): 425-434, 1999

Safe use of ursodeoxycholic acid in the treatment of dyspeptic symptoms in patients with chronic active hepatitis: a double-blind controlled trial. Journal of International Medical Research 10(4): 278-282, 1982

Treatment of chronic viral C hepatitis by interferon plus ursodeoxycholic acid Results from a controlled randomized trial in 80 patients. Hepatology 20(4 Part 2): 169A, 1994

Interferon and ursodeoxycholic acid combined therapy in the treatment of chronic viral C hepatitis: results from a controlled randomized trial in 80 patients. Hepatology 21(2): 322-327, 1995

The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis. A 12-month double-blind, placebo-controlled trial. Journal of Hepatology 20(3): 315-320, 1994

Ursodeoxycholic acid udca in active cirrhosis influence of hepatitis c virus hcv infection. Journal of Hepatology 13(Suppl. 2): S139, 1991

A randomized controlled trial of ursodeoxycholic acid udca in primary biliary cirrhosis pbc. European Journal of Clinical Investigation 19(2 Part 2): A15, 1989